DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Velcade (Bortezomib) - Renal Failure Acute - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Renal Failure Acute (79)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Velcade (Bortezomib) where reactions include renal failure acute. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 79   Next >>

Possible Velcade side effects in male

Reported by a physician from Germany on 2012-08-24

Patient: male

Reactions: Portal Hypertension, Pain, Thrombocytopenia, Epistaxis, Decreased Appetite, Renal Failure Acute, Bronchopulmonary Aspergillosis, Pseudomonas Infection, Anaemia, Hyperviscosity Syndrome, Rash, Haemangioma of Spleen, Pulmonary Sepsis, Syncope, Respiratory Failure, Visual Impairment, Leukopenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cotrim DS
    Indication: Product Used FOR Unknown Indication

Dexamethasone Sodium Phosphate
    Indication: Multiple Myeloma
    Start date: 2012-03-21
    End date: 2012-04-01

Dexamethasone Sodium Phosphate
    Start date: 2012-03-01
    End date: 2012-03-12

Dexamethasone Sodium Phosphate
    Start date: 2012-05-21
    End date: 2012-06-10

Dexamethasone Sodium Phosphate
    Start date: 2012-04-17
    End date: 2012-04-28

Doxorubicin HCL
    Indication: Multiple Myeloma
    Start date: 2012-03-21
    End date: 2012-04-01

Doxorubicin HCL
    Start date: 2012-04-17
    End date: 2012-04-28

Lenalidomide
    Indication: Multiple Myeloma
    Start date: 2012-05-21
    End date: 2012-06-10

Velcade
    Indication: Multiple Myeloma
    Start date: 2012-04-17
    End date: 2012-04-28

Velcade
    Start date: 2012-03-21
    End date: 2012-04-01

Velcade
    Start date: 2012-03-01
    End date: 2012-03-12

Other drugs received by patient: Acyclovir



Possible Velcade side effects in 17 year old male

Reported by a consumer/non-health professional from United States on 2012-08-23

Patient: 17 year old male, weighing 89.9 kg (197.8 pounds)

Reactions: Pharyngeal Inflammation, Hypoxia, Caecitis, Rash Maculo-Papular, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cefepime
    Indication: Acute Myeloid Leukaemia

Cytarabine
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-05-28

Cytarabine
    Dosage: unk
    Start date: 2012-05-18
    End date: 2012-05-18

Daunorubicin HCL
    Dosage: 50 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-05-22

Etoposide
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-05-22

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-05-26



Possible Velcade side effects in 64 year old male

Reported by a physician from United States on 2012-08-16

Patient: 64 year old male, weighing 91.7 kg (201.7 pounds)

Reactions: Fungaemia, Blood Bilirubin Increased, Histiocytosis Haematophagic, Pyrexia, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Decitabine
    Dosage: 20 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-25
    End date: 2012-07-02

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-25
    End date: 2012-07-02

Other drugs received by patient: Lisinopril; Pantoprazole; Zolpidem Tartrate; Dilaudid; Metoprolol Tartrate; Cyclobenzaprine; Cefepime; Amlodipine; Atenolol; Oxycodone HCL; Sennosides A+B; Acetylsalicylic Acid SRT; Lactulose; Polyethylene Glycol; Nexium; Clopidogrel; Docusate Sodium; Furosemide; Lorazepam; Vardenafil Hydrochloride (Levitra); Acetaminophen; Calcium Carbonate; Ceftriaxone; Metoclopramide HCL / 00041902 /; Nitroglycerin; Famotidine; Flagyl; Rosuvastatin; Acyclovir; Simethicone; Dexamethasone; Vancomycin



Possible Velcade side effects in female

Reported by a physician from United States on 2012-08-10

Patient: female, weighing 62.0 kg (136.4 pounds)

Reactions: Blood Alkaline Phosphatase Increased, Pneumonia Fungal, Dyspnoea, Hypotension, Muscular Weakness, Febrile Neutropenia, Hypokalaemia, Dehydration, Hypoxia, Pulmonary Oedema, Hypoalbuminaemia, Neutrophil Count Decreased, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Decitabine
    Dosage: 20 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-27
    End date: 2012-05-06

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-27
    End date: 2012-05-06



Possible Velcade side effects in male

Reported by a physician from United States on 2012-08-09

Patient: male, weighing 31.8 kg (70.0 pounds)

Reactions: Abdominal Pain, Atelectasis, Disseminated Intravascular Coagulation, Acidosis, Pericardial Effusion, Activated Partial Thromboplastin Time Prolonged, Multi-Organ Failure, Left Ventricular Dysfunction, Pulmonary Oedema, Mediastinal Haemorrhage, Blood Creatinine Increased, Renal Failure Acute, Dyspnoea, Angina Pectoris, Alanine Aminotransferase Increased, Hypotension, Hypercalcaemia, Respiratory Failure, Embolism, Cardiac Failure, Aspartate Aminotransferase Increased, Ventricular Tachycardia, Ejection Fraction Decreased, Hypoalbuminaemia, Ventricular Fibrillation, Sinus Tachycardia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Ativan
    Indication: Product Used FOR Unknown Indication

Cytarabine
    Dosage: 100 mg/kg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-11

Daunorubicin HCL
    Dosage: 50 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-05

Etoposide
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-05

Fentanyl
    Indication: Product Used FOR Unknown Indication

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-01



Possible Velcade side effects in male

Reported by a physician from Germany on 2012-08-07

Patient: male

Reactions: Portal Hypertension, Pain, Thrombocytopenia, Decreased Appetite, Renal Failure Acute, Epistaxis, Bronchopulmonary Aspergillosis, Pseudomonas Infection, Anaemia, Hyperviscosity Syndrome, Rash, Pulmonary Sepsis, Haemangioma of Spleen, Syncope, Respiratory Failure, Visual Impairment, Leukopenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cotrim DS
    Indication: Product Used FOR Unknown Indication

Dexamethasone Sodium Phosphate
    Start date: 2012-05-21
    End date: 2012-06-10

Dexamethasone Sodium Phosphate
    Indication: Multiple Myeloma
    Start date: 2012-04-17
    End date: 2012-04-28

Dexamethasone Sodium Phosphate
    Start date: 2012-03-01
    End date: 2012-03-12

Dexamethasone Sodium Phosphate
    Start date: 2012-03-21
    End date: 2012-04-01

Doxorubicin HCL
    Indication: Multiple Myeloma
    Start date: 2012-04-17
    End date: 2012-04-28

Doxorubicin HCL
    Start date: 2012-03-21
    End date: 2012-04-01

Lenalidomide
    Indication: Multiple Myeloma
    Start date: 2012-05-21
    End date: 2012-06-10

Velcade
    Indication: Multiple Myeloma
    Start date: 2012-03-01
    End date: 2012-03-12

Velcade
    Start date: 2012-04-17
    End date: 2012-04-28

Velcade
    Start date: 2012-03-21
    End date: 2012-04-01

Other drugs received by patient: Acyclovir



Possible Velcade side effects in male

Reported by a physician from Germany on 2012-08-06

Patient: male

Reactions: Portal Hypertension, Pain, Thrombocytopenia, Epistaxis, Decreased Appetite, Renal Failure Acute, Bronchopulmonary Aspergillosis, Anaemia, Pseudomonas Infection, Hyperviscosity Syndrome, Rash, Pulmonary Sepsis, Haemangioma of Spleen, Syncope, Respiratory Failure, Visual Impairment, Leukopenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cotrim DS
    Indication: Product Used FOR Unknown Indication

Dexamethasone Sodium Phosphate
    Indication: Multiple Myeloma
    Start date: 2012-04-17
    End date: 2012-04-28

Dexamethasone Sodium Phosphate
    Start date: 2012-03-21
    End date: 2012-04-01

Dexamethasone Sodium Phosphate
    Start date: 2012-05-21
    End date: 2012-06-10

Dexamethasone Sodium Phosphate
    Start date: 2012-03-01
    End date: 2012-03-12

Doxorubicin HCL
    Start date: 2012-03-21
    End date: 2012-04-01

Doxorubicin HCL
    Indication: Multiple Myeloma
    Start date: 2012-04-17
    End date: 2012-04-28

Lenalidomide
    Indication: Multiple Myeloma
    Start date: 2012-05-21
    End date: 2012-06-10

Velcade
    Indication: Multiple Myeloma
    Start date: 2012-03-01
    End date: 2012-03-12

Velcade
    Start date: 2012-04-17
    End date: 2012-04-28

Velcade
    Start date: 2012-03-21
    End date: 2012-04-01

Other drugs received by patient: Acyclovir



Possible Velcade side effects in 66 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-30

Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)

Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Acute Myocardial Infarction, Clostridial Infection, Immunosuppression, Renal Failure Acute, Cardiac Failure Congestive, Pneumonia, Dyspnoea, Malnutrition, Febrile Neutropenia, Encephalopathy, Atrial Fibrillation, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-18
    End date: 2011-06-02

Dexamethasone
    End date: 2012-04-10

Prednisone
    Indication: Multiple Myeloma

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-20
    End date: 2011-06-09

Revlimid
    Administration route: Oral
    End date: 2012-05-01

Velcade
    Dosage: .2714 milligram
    Indication: Multiple Myeloma
    Start date: 2010-12-12
    End date: 2011-06-02

Velcade
    End date: 2012-04-10

Other drugs received by patient: Lotrel; Pravastatin; Vitamin D; Coreg; Doxepin; Tricore; Betaseron; Acyclovir; Allopurinol; Aspirin; Heocyte; Metformin Hydrochloride; Warfarin Sodium; Doxil



Possible Velcade side effects in

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-25

Patient:

Reactions: Off Label Use, Vomiting, Dehydration, Septic Shock, Renal Failure Acute, Haemodynamic Instability

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Melphalan Hydrochloride
    Dosage: unk
    Indication: Amyloidosis
    Start date: 2011-10-10
    End date: 2011-10-12

Velcade
    Dosage: 3.5 mg, unk
    Indication: Amyloidosis
    Start date: 2011-10-10
    End date: 2011-10-12

Other drugs received by patient: Valsartan; Atorvastatin; Nexium; Prednisone



Possible Velcade side effects in male

Reported by a physician from United States on 2012-07-24

Patient: male, weighing 31.8 kg (70.0 pounds)

Reactions: Atelectasis, Abdominal Pain, Disseminated Intravascular Coagulation, Acidosis, Pericardial Effusion, Multi-Organ Failure, Activated Partial Thromboplastin Time Prolonged, Left Ventricular Dysfunction, Pulmonary Oedema, Mediastinal Haemorrhage, Blood Creatinine Increased, Renal Failure Acute, Dyspnoea, Angina Pectoris, Hypotension, Alanine Aminotransferase Increased, Hypercalcaemia, Embolism, Cardiac Failure, Respiratory Failure, Ventricular Tachycardia, Ejection Fraction Decreased, Aspartate Aminotransferase Increased, Hypoalbuminaemia, Ventricular Fibrillation, Sinus Tachycardia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Ativan
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Cytarabine
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-11

Cytarabine
    Dosage: 100 mg/kg, bid
    Start date: 2012-06-01
    End date: 2012-06-03

Daunorubicin Hydrochloride
    Dosage: 50 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-05

Etoposide
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-05

Fentanyl
    Indication: Product Used FOR Unknown Indication

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-01



Possible Velcade side effects in 66 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18

Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)

Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Death, Acute Myocardial Infarction, Clostridial Infection, Cardiac Failure Congestive, Immunosuppression, Renal Failure Acute, Pneumonia, Dyspnoea, Malnutrition, Atrial Fibrillation, Febrile Neutropenia, Encephalopathy, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-18
    End date: 2011-06-02

Dexamethasone
    End date: 2012-04-10

Prednisone
    Indication: Multiple Myeloma

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-20
    End date: 2011-06-09

Revlimid
    Administration route: Oral
    End date: 2012-05-01

Velcade
    End date: 2012-04-10

Velcade
    Dosage: .2714 milligram
    Indication: Multiple Myeloma
    Start date: 2010-12-12
    End date: 2011-06-02

Other drugs received by patient: Doxil; Coreg; Pravastatin; Heocyte; Betaseron; Lotrel; Aspirin; Vitamin D; Warfarin Sodium; Allopurinol; Doxepin; Acyclovir; Metformin Hydrochloride; Tricore



Possible Velcade side effects in male

Reported by a consumer/non-health professional from United States on 2012-07-17

Patient: male, weighing 31.8 kg (70.0 pounds)

Reactions: Abdominal Pain, Acidosis, Pericardial Effusion, Left Ventricular Dysfunction, Hypocalcaemia, Renal Failure Acute, Pneumonitis, Dyspnoea, Angina Pectoris, Hypotension, Anaemia, Delirium, Tumour Lysis Syndrome, Respiratory Failure, Cardiac Failure, Aspartate Aminotransferase Increased, Ejection Fraction Decreased, Sinus Tachycardia, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Ativan
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Cytarabine
    Dosage: 100 mg/kg, bid
    Start date: 2012-06-01
    End date: 2012-06-03

Cytarabine
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-11

Daunorubicin Hydrochloride
    Dosage: 50 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-05

Etoposide
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-05

Fentanyl
    Indication: Product Used FOR Unknown Indication

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-01



Possible Velcade side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-16

Patient: female, weighing 59.0 kg (129.7 pounds)

Reactions: Vomiting, Fatigue, Nausea, Oesophagitis, Dehydration, Urinary Tract Infection, Hypotension, Systemic Inflammatory Response Syndrome, Lobar Pneumonia, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Velcade

Other drugs received by patient: Prilosec; Colace; Prozac; Fentanyl; Potassium Chloride; Vicodin; Iron; Atenolol; Synthroid; Warfarin Sodium



Possible Velcade side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-13

Patient: male, weighing 83.9 kg (184.6 pounds)

Reactions: Duodenitis, Multi-Organ Failure, Abdominal Pain, Oesophagitis, Sepsis, Anaemia, Multiple Myeloma, Hypertension, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Velcade

Other drugs received by patient: Hydrocodone Bitartrate + Acetaminophen; Multi-Vitamins; Ranitidine; Decadron; Aspirin; Naproxen; Nifedipine



Possible Velcade side effects in 66 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-13

Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)

Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Death, Acute Myocardial Infarction, Clostridial Infection, Renal Failure Acute, Immunosuppression, Cardiac Failure Congestive, Pneumonia, Dyspnoea, Malnutrition, Febrile Neutropenia, Atrial Fibrillation, Encephalopathy, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-18
    End date: 2011-06-02

Dexamethasone
    End date: 2012-04-10

Prednisone
    Indication: Multiple Myeloma

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-20
    End date: 2011-06-09

Revlimid
    Administration route: Oral
    End date: 2012-05-01

Velcade
    End date: 2012-04-10

Velcade
    Dosage: .2714 milligram
    Indication: Multiple Myeloma
    Start date: 2010-12-12
    End date: 2011-06-02

Other drugs received by patient: Betaseron; Lotrel; Coreg; Doxepin; Vitamin D; Warfarin Sodium; Pravastatin; Doxil; Acyclovir; Allopurinol; Heocyte; Tricore; Aspirin; Metformin Hydrochloride



Possible Velcade side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-06

Patient:

Reactions: Death, Dehydration, Hypotension, Mental Status Changes, Clostridial Infection, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Dexamethasone

Revlimid
    Administration route: Oral

Velcade



Possible Velcade side effects in

Reported by a pharmacist from Netherlands on 2012-07-06

Patient:

Reactions: Diarrhoea, Oliguria, Colitis, Pyrexia, Thrombocytopenia, Leukopenia, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Velcade

Other drugs received by patient: Valaciclovir; Cyclophosphamide; Fluconazole; Cotrim; Dexamethasone



Possible Velcade side effects in male

Reported by a pharmacist from Netherlands on 2012-07-06

Patient: male, weighing 80.0 kg (176.0 pounds)

Reactions: Colitis, Thrombocytopenia, Leukopenia, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Multiple Myeloma
    Start date: 2012-05-04

Velcade
    Indication: Multiple Myeloma
    Start date: 2012-05-04

Other drugs received by patient: Fluconazole; Valaciclovir; Dexamethasone; Cotrim



Possible Velcade side effects in male

Reported by a consumer/non-health professional from United States on 2012-07-05

Patient: male

Reactions: Cellulitis, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Velcade



Possible Velcade side effects in male

Reported by a pharmacist from United States on 2012-06-29

Patient: male, weighing 21.3 kg (46.9 pounds)

Reactions: B-Cell Lymphoma, Hypotension, Alanine Aminotransferase Increased, Pancytopenia, Roseolovirus Test Positive, Aspartate Aminotransferase Increased, Venoocclusive Liver Disease, Acute Respiratory Distress Syndrome, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Product Used FOR Unknown Indication

Fludarabine Phosphate
    Indication: Product Used FOR Unknown Indication

Mesna
    Indication: Product Used FOR Unknown Indication

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: B-Cell Lymphoma
    Start date: 2011-12-27
    End date: 2012-01-16



Possible Velcade side effects in 65 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-28

Patient: 65 year old female, weighing 78.9 kg (173.6 pounds)

Reactions: Hypotension, Anaemia, Electrolyte Imbalance, Thrombocytopenia, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-12-01
    End date: 2012-06-18

Velcade
    Dosage: 1 milligram
    Indication: Multiple Myeloma
    Start date: 2011-11-30
    End date: 2012-04-30



Possible Velcade side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-28

Patient: male, weighing 71.4 kg (157.1 pounds)

Reactions: Death, Anaemia, Thrombocytopenia, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Indication: Multiple Myeloma

Persantine
    Dosage: 75 mg, unk
    Indication: Product Used FOR Unknown Indication

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma
    Start date: 2010-09-28
    End date: 2010-10-08

Other drugs received by patient: Uroxatral; Aspirin; Coreg; Dipyridamole; SAW Palmetto / 00833501 /; Temazepam; Calcium; Coumadin; Furosemide; Atorvastatin; Carvedilol; Vitamin D; Sodium Chloride; Benicar; Amiodarone Hydrochloride; Diphenhydramine HCL; Pacerone; Acetaminophen; Alfuzosin Hydrochloride



Possible Velcade side effects in 62 year old female

Reported by a physician from United States on 2012-06-27

Patient: 62 year old female, weighing 62.0 kg (136.4 pounds)

Reactions: Pneumonia Fungal, Blood Alkaline Phosphatase Increased, Dyspnoea, Hypotension, Febrile Neutropenia, Muscular Weakness, Hypokalaemia, Dehydration, Hypoxia, Hypoalbuminaemia, Pulmonary Oedema, Neutrophil Count Decreased, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Decitabine
    Dosage: 20 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-27
    End date: 2012-05-06

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-27
    End date: 2012-05-06



Possible Velcade side effects in

Reported by a consumer/non-health professional from Colombia on 2012-06-22

Patient:

Reactions: Renal Failure Acute, Peritonitis

Adverse event resulted in: death

Drug(s) suspected as cause:
Velcade

Other drugs received by patient: Dexamethasone



Possible Velcade side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-22

Patient: male, weighing 101.6 kg (223.5 pounds)

Reactions: Urinary Tract Infection, Pain, Mental Status Changes, Neoplasm Progression, Mantle Cell Lymphoma, Haemodialysis, Lymphocytosis, Cardiac Failure, Platelet Count Decreased, Renal Failure Acute

Adverse event resulted in: death

Drug(s) suspected as cause:
Temsirolimus
    Dosage: 25 mg weekly iv
    Indication: Mantle Cell Lymphoma
    Start date: 2012-04-04
    End date: 2012-05-16

Velcade
    Dosage: 1.6 mg/m2 weekly iv
    Indication: Mantle Cell Lymphoma
    Start date: 2012-04-04
    End date: 2012-05-16



Possible Velcade side effects in male

Reported by a physician from United States on 2012-06-19

Patient: male, weighing 102.1 kg (224.6 pounds)

Reactions: Death, Dyspnoea, Fatigue, Urinary Tract Infection, Atrial Fibrillation, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Temsirolimus
    Dosage: 25 mg, weekly
    Indication: Mantle Cell Lymphoma
    Start date: 2012-04-04
    End date: 2012-05-16

Velcade
    Dosage: 1.6 mg/m2, weekly
    Indication: Mantle Cell Lymphoma
    Start date: 2012-04-04
    End date: 2012-05-16



Possible Velcade side effects in 17 year old male

Reported by a physician from United States on 2012-06-15

Patient: 17 year old male, weighing 89.9 kg (197.8 pounds)

Reactions: Pharyngeal Inflammation, Hypoxia, Caecitis, Rash Maculo-Papular, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cefepime
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Cytarabine
    Dosage: unk
    Start date: 2012-05-18
    End date: 2012-05-18

Cytarabine
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-05-28

Daunorubicin Hydrochloride
    Dosage: 50 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-05-22

Etoposide
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-05-22

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-05-26



Possible Velcade side effects in male

Reported by a physician from United States on 2012-06-14

Patient: male, weighing 102.1 kg (224.6 pounds)

Reactions: Death, Dyspnoea, Fatigue, Urinary Tract Infection, Atrial Fibrillation, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Temsirolimus
    Dosage: 25 mg, weekly
    Indication: Mantle Cell Lymphoma
    Start date: 2012-04-04
    End date: 2012-05-16

Velcade
    Dosage: 1.6 mg/m2, weekly
    Indication: Mantle Cell Lymphoma
    Start date: 2012-04-04
    End date: 2012-05-16



Possible Velcade side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-08

Patient: male, weighing 102.1 kg (224.6 pounds)

Reactions: Dyspnoea, Urinary Tract Infection, Atrial Fibrillation, Neoplasm Progression, Mental Status Changes, Mantle Cell Lymphoma, Haemodialysis, Fatigue, Cardiac Failure, Renal Failure Acute

Adverse event resulted in: death

Drug(s) suspected as cause:
Temsirolimus
    Indication: Mantle Cell Lymphoma
    Start date: 2012-04-04
    End date: 2012-05-16

Velcade
    Indication: Mantle Cell Lymphoma
    Start date: 2012-04-04
    End date: 2012-05-16



Possible Velcade side effects in male

Reported by a consumer/non-health professional from United States on 2012-06-08

Patient: male

Reactions: Hypophosphataemia, Decubitus Ulcer, Urinary Tract Infection, Tachycardia, Hyperglycaemia, Hypomagnesaemia, Hypoxia, Urinary Retention, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 500 mg/m2, cyclic
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: 40 mg, cyclic
    Administration route: Oral
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma
    Start date: 2011-09-30



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017